Top Brain-Computer Interfaces companies 2026

#04

Ceribell

CBLL

Offers a rapid-deployment EEG system with AI-powered seizure detection for emergency and ICU settings.

Non-Invasive Clinical EEG · IPO $207.3M

Non-Invasive Clinical EEG

#05

Delivers a motor neuroprosthesis via the jugular vein into brain blood vessels, avoiding open brain surgery.

Endovascular BCI · Series D $200M

#06

Offers EEG-based brain-sensing headbands for education, focus training, prosthetic control, and wellness applications.

Non-Invasive Consumer EEG · Series B+ $286M

Non-Invasive Consumer EEG

#07

OpenAI-backed research lab building non-invasive, high-bandwidth brain-computer interfaces that read and write to neurons using molecules and ultrasound instead of implanted electrodes.

Non-Invasive Neuroimaging · Seed $250M

Non-Invasive Neuroimaging

#08

Provides virtual-reality and brain-sensing platforms for stroke rehabilitation and neurological recovery, combining VR with EEG-based neurofeedback.

Non-Invasive Clinical EEG · Growth $125M

Non-Invasive Clinical EEG

#09

Manufactures the Utah Array and other electrode systems used in academic BCI research and clinical trials for over a decade.

Invasive Cortical Implants · Strategic Investment $200M

Invasive Cortical Implants

Strategic Investment

$200M

HQ

#10

Precision Neuroscience

Develops a flexible, thin-film electrode array placed on the brain surface to enable high-resolution neural recording with minimally-invasive placement.

Invasive Cortical Implants · Series C $102M

Invasive Cortical Implants

#11

Develops spinal cord stimulation platforms to restore movement and function in patients with spinal cord injury.

Spinal & Peripheral Interfaces · IPO $89.6M

Spinal & Peripheral Interfaces

#12

Develops the RNS System, a responsive neurostimulation device that detects and treats epileptic seizures in real time.

Neuromodulation & Stimulation · IPO $105.2M

Neuromodulation & Stimulation

IPO

$105.2M

HQ

#13

INBRAIN Neuroelectronics

Engineers graphene-based neural interfaces for high-resolution, biocompatible brain recording and stimulation.

Next-Gen Electrodes & Materials · Series B $50M

Next-Gen Electrodes & Materials

#14

Develops soft, flexible neural electrode arrays designed to minimize scarring and improve long-term biocompatibility in brain implants.

Next-Gen Electrodes & Materials · Series A $55M

Next-Gen Electrodes & Materials

#15

Produces wearable time-domain functional near-infrared spectroscopy headsets for brain activity measurement in research and commercial settings.

Non-Invasive Neuroimaging · Series C $53M

Non-Invasive Neuroimaging

#16

Builds very-high-density cortical implants targeting tens of thousands of electrodes for speech and communication restoration.

Invasive Cortical Implants · Series A $33M

Invasive Cortical Implants

#17

Embeds EEG sensors into everyday headphones to track focus, attention, and cognitive state for productivity and wellness.

Non-Invasive Consumer EEG · Series A $35M

Non-Invasive Consumer EEG

#18

Develops minimally-invasive implanted muscle-machine (neuromuscular) interfaces for prosthetic and robotic control.

Spinal & Peripheral Interfaces · Series A $19M

Spinal & Peripheral Interfaces

#19

Designs miniaturized, wireless neural implants with on-board AI processing to decode brain signals locally and reduce data bandwidth requirements.

Invasive Cortical Implants · Seed $10M

Invasive Cortical Implants

#20

Develops in-ear EEG biosensors for continuous brain activity monitoring in wearable form-factors.

Non-Invasive Consumer EEG · Series A $16M

Non-Invasive Consumer EEG

#21

Develops magnetoelectric neural stimulation technology for non-invasive, deep-brain modulation targeting psychiatric and neurological disorders.

Neuromodulation & Stimulation · Series A $18.8M

Neuromodulation & Stimulation

#22

Develops non-invasive transcranial electrical stimulation and EEG systems for research and clinical applications in epilepsy and neurorehabilitation.

Neuromodulation & Stimulation · Series A $17.5M

Neuromodulation & Stimulation

#23

Forest Neurotech is developing an ultrasound-based brain-computer interface for whole-brain imaging and neuromodulation, aiming to read from and stimulate deep brain structures less invasively than electrode implants.

Next-Gen Electrodes & Materials · Series A $14M

Next-Gen Electrodes & Materials

#24

Produces augmented-reality headsets with integrated EEG for non-verbal communication and assistive technology for patients with speech and motor impairments.

Assistive BCI Devices · Seed $1.8M

Assistive BCI Devices

#25

Builds a wearable headband that uses real-time EEG and acoustic stimulation to accelerate sleep onset and improve sleep quality.

Non-Invasive Consumer EEG · Seed $12M

Non-Invasive Consumer EEG

Seed

$12M

HQ